Equities researchers at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a note issued to investors on Saturday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
Ampio Pharmaceuticals stock opened at $0.00 on Friday. The stock’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.01. The stock has a market cap of $2,383.50, a PE ratio of 0.00 and a beta of 3.78. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $1.99.
About Ampio Pharmaceuticals
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- How to Build the Ultimate Everything ETF Portfolio
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What Does Downgrade Mean in Investing?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
